期刊文献+

甲状腺髓样癌术后的病情监测 被引量:7

Detection of remnants after removal of medullary thyroid carcinoma
原文传递
导出
摘要 目的 研究判断甲状腺髓样癌 (MTC)患者手术是否成功以及残余病灶定位的方法。 方法 对 14例MTC术后的患者进行了钙负荷 降钙素激发试验 ,并检测血癌胚抗原 (CEA)、胃泌素(GST)、肠血管活性肽 (VIP) ,同时对降钙素增高的患者进行生长抑素受体 (somatostain receptor,SS R)核素显像。 结果  14例患者钙负荷 降钙素激发试验后降钙素峰值均升高 (9 3~ 2 2 49 8μg/L) ,其中 7例患者降钙素基础值异常升高 (6 9 7~ 16 6 9 1ng/L) ,峰值更高 ;对其 7例进一步进行SS R显像后 ,均显像阳性 ,而 14例患者的CEA、VIP及GST测定值均在正常范围。 结论 对MTC术后的患者进行钙负荷 降钙素激发试验十分必要 ,特别是对血降钙素轻度增高的患者 ,可及时判断体内是否有残余病灶 ;SS R显像有助于病灶的定位 ;CEA、VIP及GST测定对MTC(包括伴有腹泻症状者 )术后监测意义不大。 Objective[WT5”BZ] To assess whether calcium stimulation test or somatostain receptor(SS R) imaging could early detect remnants after removal of medullary thyroid carcinoma(MTC). [WT5”HZ]Methods[WT5”BZ] Calcitonin stimulation (calcium element 3 mg/kg weight, i.v.10 min),carcino embryonic antigen(CEA),gastrin(GST) and vasoactive intestinal peptide(VIP) were tested in 14 patients with postoperative MTC. SS R imaging was used to localize the remnants after removal of MTC in patients with elevated calcitonin. [WT5”HZ]Results[WT5”BZ] Calcitonin stimulation test showed that the peak value of serum calcitonin was elevated in all patients, of whom 7 had the elevated vatue of basic calcitonin and peak calcitonin. In the 7 patients, SS R imaging showed normal CEA, GST and VIP. [WT5”HZ]Conclusions[WT5”BZ] It is necessary for patients after removal of MTC to perform calcitonin stimulation test for detecting remnants early. SS R imaging may be useful for localizing remnants and metastatic foci. CEA,GST and VIP are not significant in monitoring MTC after operation. [WT5”HZ]
出处 《中华外科杂志》 CAS CSCD 北大核心 2000年第1期19-21,共3页 Chinese Journal of Surgery
关键词 甲状腺肿瘤 甲状腺髓样癌 SS-R Thyroid neoplasms Carcinoma,medullary Receptor,somatostain Calcitonin Radionuclide imaging
  • 相关文献

参考文献2

二级参考文献15

同被引文献61

  • 1高明,于洋,李树玲,徐本义,孙保存,刘经组.58例甲状腺髓样癌降钙素及其基因相关肽检测的临床意义[J].中国肿瘤临床,2004,31(14):784-787. 被引量:4
  • 2李树玲,杨力珍.甲状腺髓样癌[J].普外临床,1989,4(1):52-55. 被引量:11
  • 3张建平.降钙素与肺癌[J].国外医学(呼吸系统分册),1995,15(3):120-123. 被引量:4
  • 4吴毅.甲状腺髓样癌的外科治疗[J].中国普外基础与临床杂志,2006,13(3):250-251. 被引量:3
  • 5高再荣,安锐,张永学,Hans J.Biersack.核素靶向治疗在转移性甲状腺髓样癌治疗中的价值[J].中华肿瘤杂志,2006,28(8):621-624. 被引量:8
  • 6同济医科大学病理教研室 中山医科大学病理教研室.外科病理学[M].武汉:湖北科学技术出版社,1999.1170.
  • 7Kebebew E, ltuarte PH, Siperstein AE, et al. Medullary thyroid carcinoma : clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer, 2000, 88: 1139-1148.
  • 8Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer, 1996, 78 : 2173-2183.
  • 9Fuchshuber PR, Loree TR, Hicks WL Jr, et al. Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Ann Surg Oncol, 1998, 5:81-86.
  • 10Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs acalcitonine. Clin Endoerinol ( Oxf), 1998, 48: 265 -273.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部